ACE2 and COVID-19: Our study may provide an explicit evidence of the influence of COVID‐19 on high and low vulnerable cancer patients and the association between the expression level of ACE2 and the prognosis of various cancer types, attracting more attention to survival rate evaluation of the cancer patients recovered from COVID‐19 infection.